Latest From Biotech Now

Bioterrorism: Assessing the Threat

AB23475

Recently, the House of Representatives Homeland Security Committee Subcommittee on Emergency Preparedness, Response, and Communications held a hearing on bioterrorism and biological warfare.Tom Inglesby, MD, University of Pittsburgh Medical Center, Center for Health Security and Robert P. Kadlec, MD, Center for a New American Security, presented testimony outlining their concerns on current threats to public safety and recommendations for emergency preparedness. Drs. Inglesby and Kadlec asserted that the risk of biological attacks on the U.S. Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Physician Payments Sunshine Act: Collaboration Key for Doctors & Biopharmas

Jim Greenwood

In a letter to the editor on USA Today, BIO CEO Jim Greenwood and John J. Castellani, president of PhRMA, write that context must accompany the data being provided under the Physician Payments Sunshine Act: “Discovery of new and improved medicines would be impossible without collaborations between physicians and biopharmaceutical companies. Consider ongoing research and clinical trials that not only make medicines possible, but also help our understanding of disease. Biopharmaceutical professionals help physicians stay Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

No, GMOs Won’t Harm Your Health

Canola-115x76

In a recent Mother Jones Inquiring Minds piece, Indre Viskontas interviewed Dr. Steven Novella, a renowned neurologist at Yale University. Dr. Novella does a wonderful job of outlining the myths and facts surrounding Genetically Modified Organisms: “Almost everything I hear about [industrial agriculture] is a myth. It’s such an emotional issue—a highly ideological and politicized issue—that what I find is that most of what people write and say and believe about it just fits into some Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,

U.S. Rep. Charlie Dent Discusses PDUFA and NIH Funding at #BIOCEO14

Dent

During the 16th Annual BIO CEO & Investor Conference, U.S. Representative Charlie Dent of Pennsylvania, co- chair of the Congressional Biomedical Research Caucus, joined BIO’s Fritz Bittenbender to discuss the biotech industry in Pennsylvania as well as recent legislative developments affecting the industry. Dent points to the recent omnibus spending agreement which allowed the Food and Drug Administration (FDA) to access user $85 million in user fees sequestered in 2013. These fees are paid to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

The 2014 Farm Bill Becomes Law at MSU

farm-bill-signing-group-shot-115x76

The Lansing State Journal recently published an noteworthy editorial titled Allen Julian and Peter Pellerito: MSU a good site to sign Farm Bill. Allen Julian is the chief business officer of MBI International and Peter Pellerito is a senior policy Consultant at the Biotechnology Industry Organization. Both provide readers excellent insight to why Michigan was a fitting choice for the final signing of the 2014 Farm Bill: When President Obama toured the MBI facility and Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , ,